Integrated chemical manufacturer Epigral Ltd (formerly Meghmani Finechem Ltd), announced its expansion into Chlorinated polyvinyl chloride (CPVC) Compounds.

With a capacity of 35,000 TPA, the CPVC Compound manufacturing plant is expected to get commissioned by Q4FY24 at Dahej, Gujarat.

In July 2022, Epigral commissioned CPVC Resin capacity of 30,000 TPA. This was followed by the company announcing further increase in capacity to 75,000 TPA by Q4FY24, a part of which will be utilised for CPVC Compound manufacturing with an additional capex of Rs. 25 crore. With this expansion, Epigral will be catering to both, CPVC Resin and CPVC Compound customers in the country.

Resistant to high heat and chemicals, CPVC Resin is widely used in manufacturing pipes for industrial and domestic purposes. India is net importer of CPVC Resin and CPVC Compound demand. With Epigral venturing into manufacturing CPVC Compounds, the company aims at adding to domestic supply volume, thereby contributing in bridging the demand and supply gap.

Speaking on the development, Maulik Patel, Chairman & Managing Director, Epigral Limited said: “We have been expansively contributing to this market for over a year now, which has enabled us to gather invaluable market and sector insights. Intensified growth of construction industry in India, along with growing applications of CPVC, presents with immense growth opportunities”

“This expansion is in synergy with our capex of CPVC Resin. As an aspirational and dynamic company, we are expecting more expansions in future to keep our growth momentum consistent,” Patel added.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai